Marizyme Inc. Wins FDA Nod for DuraGraft Storage Advancement
Qualigen Announced An Agreement With Marizyme To Commercialize DuraGraft
Marizyme Announces Director Julie Kampf's Resignation
Marizyme Inc CEO Releases Corporate Update Including Details of Key Progress on DuraGraft
InvestmentPitch Media Video Features Marizyme's CEO David Barthel Discussing Receipt of FDA Clearance for Its Flagship DuraGraft Medical Device
VANCOUVER, BC / ACCESSWIRE / October 13, 2023 / Marizyme, Inc. (OTCQB:MRZM), a global multi-technology biomedical company dedicated to the accelerated development and commercialization of medical tech
The Watchlist by The Market Herald Releases New Interviews With Marizyme, Regenx, BuildDirect, and Three Sixty Solar Discussing Their Latest News
VANCOUVER, BC / ACCESSWIRE / October 6, 2023 / The Watchlist by The Market Herald has announced the release of new interviews with FPX Nickel, Pelangio Exploration, Nicola Mining, and Max Resource dis
Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft
DuraGraft is the first and only FDA cleared medical device for use as an intra-operative vascular conduit storage and flushing solution used during CABG surgeries JUPITER, FL, Oct. 06, 2023 (GLOBE NEWSWIRE) -- via
Marizyme CEO Delivers Business Update
JUPITER, FL, May 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Marizyme, Inc. ("Marizyme" or the "Company") (OTCQB: MRZM), today provided the following business update to the stockholders and the
No Data